tetano
Editor, Senior Moderator
Viral Immunol
. 2023 Jan;36(1):63-70.
doi: 10.1089/vim.2022.0117.
D614G SARS-CoV-2 Pseudovirus Infectivity and Binding of Spike Protein to the ACE2 Receptor Inversely Correlates with Serum SARS-CoV-2-Specific IgG Levels
Laura McCullagh[SUP] 1 [/SUP], Noreen Sheehy[SUP] 2 [/SUP], Cillian F De Gascun[SUP] 1 [/SUP], Jaythoon Hassan[SUP] 1 [/SUP]
Affiliations
Abstract
Understanding the functional characteristics of antibodies produced against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) will assist in the determination of disease outcomes for this virus. In this study, the ability of antibodies to inhibit viral entry into the host cell through the interaction of the receptor binding domain of the viral spike protein and the angiotensin-converting enzyme 2 receptor on the human cell surface was investigated. The SARS-CoV-2 IgG levels in 20 SARS-CoV-2 positive patients were measured using an enzyme-linked immunosorbent assay, and the samples were further analyzed using a functional binding assay. Inhibition of viral infectivity was also measured using a pseudovirus neutralization assay against a D614G SARS-CoV-2 virus strain. A significant correlation between IgG levels and neutralizing antibody 50% inhibitory concentration (IC[SUB]50[/SUB]) titers was observed (p < 0.05). Similarly, the IC[SUB]50[/SUB] titers obtained in the neutralization and binding assays were significantly correlated (p < 0.001). Varying levels of IgG and IC[SUB]50[/SUB] titers were observed for the SARS-CoV-2 antibody-positive samples, with one sample not showing any neutralizing capability despite detectable IgG levels. Gender comparisons showed no statistical differences in any of the assays. These results suggest that increased SARS-CoV-2 IgG levels correlate with greater protection against the entry of the virus into cells; however, further investigations in larger studies are needed to confirm the correlates of protection.
Keywords: ACE2 receptor; SARS-CoV-2; coronavirus; neutralizing assay; pseudovirus; spike protein.
. 2023 Jan;36(1):63-70.
doi: 10.1089/vim.2022.0117.
D614G SARS-CoV-2 Pseudovirus Infectivity and Binding of Spike Protein to the ACE2 Receptor Inversely Correlates with Serum SARS-CoV-2-Specific IgG Levels
Laura McCullagh[SUP] 1 [/SUP], Noreen Sheehy[SUP] 2 [/SUP], Cillian F De Gascun[SUP] 1 [/SUP], Jaythoon Hassan[SUP] 1 [/SUP]
Affiliations
- PMID: 36648773
- DOI: 10.1089/vim.2022.0117
Abstract
Understanding the functional characteristics of antibodies produced against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) will assist in the determination of disease outcomes for this virus. In this study, the ability of antibodies to inhibit viral entry into the host cell through the interaction of the receptor binding domain of the viral spike protein and the angiotensin-converting enzyme 2 receptor on the human cell surface was investigated. The SARS-CoV-2 IgG levels in 20 SARS-CoV-2 positive patients were measured using an enzyme-linked immunosorbent assay, and the samples were further analyzed using a functional binding assay. Inhibition of viral infectivity was also measured using a pseudovirus neutralization assay against a D614G SARS-CoV-2 virus strain. A significant correlation between IgG levels and neutralizing antibody 50% inhibitory concentration (IC[SUB]50[/SUB]) titers was observed (p < 0.05). Similarly, the IC[SUB]50[/SUB] titers obtained in the neutralization and binding assays were significantly correlated (p < 0.001). Varying levels of IgG and IC[SUB]50[/SUB] titers were observed for the SARS-CoV-2 antibody-positive samples, with one sample not showing any neutralizing capability despite detectable IgG levels. Gender comparisons showed no statistical differences in any of the assays. These results suggest that increased SARS-CoV-2 IgG levels correlate with greater protection against the entry of the virus into cells; however, further investigations in larger studies are needed to confirm the correlates of protection.
Keywords: ACE2 receptor; SARS-CoV-2; coronavirus; neutralizing assay; pseudovirus; spike protein.